BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23555969)

  • 1. Molecular basis of live-attenuated influenza virus.
    He W; Wang W; Han H; Wang L; Zhang G; Gao B
    PLoS One; 2013; 8(3):e60413. PubMed ID: 23555969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.
    Nogales A; Steel J; Liu WC; Lowen AC; Rodriguez L; Chiem K; Cox A; García-Sastre A; Albrecht RA; Dewhurst S; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0007822. PubMed ID: 35583364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.
    Cox A; Schmierer J; D'Angelo J; Smith A; Levenson D; Treanor J; Kim B; Dewhurst S
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33142846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.
    Rodriguez L; Blanco-Lobo P; Reilly EC; Maehigashi T; Nogales A; Smith A; Topham DJ; Dewhurst S; Kim B; Martínez-Sobrido L
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31658679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.
    Solórzano A; Ye J; Pérez DR
    J Virol; 2010 May; 84(9):4587-96. PubMed ID: 20181702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
    Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
    J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
    Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
    Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus.
    Klimov AI; Cox NJ; Yotov WV; Rocha E; Alexandrova GI; Kendal AP
    Virology; 1992 Feb; 186(2):795-7. PubMed ID: 1733114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.
    Zhou B; Meliopoulos VA; Wang W; Lin X; Stucker KM; Halpin RA; Stockwell TB; Schultz-Cherry S; Wentworth DE
    J Virol; 2016 Oct; 90(19):8454-63. PubMed ID: 27440882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine].
    Medvedeva TE; Kudriavtseva VK; Nevedomskaia GN; Zhikhareva IV; Gushchina MI; Zolotarev FN; Vodeĭko GM; Lisovskaia KV; Iotov VV; Khaĭder MI
    Genetika; 1993 Apr; 29(4):681-9. PubMed ID: 8354475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.
    Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG
    Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).
    Isakova-Sivak I; Chen LM; Matsuoka Y; Voeten JT; Kiseleva I; Heldens JG; den Bosch Hv; Klimov A; Rudenko L; Cox NJ; Donis RO
    Virology; 2011 Apr; 412(2):297-305. PubMed ID: 21315402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.
    Zhou B; Li Y; Speer SD; Subba A; Lin X; Wentworth DE
    Vaccine; 2012 May; 30(24):3691-702. PubMed ID: 22449422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA.
    Li J; Arévalo MT; Diaz-Arévalo D; Chen Y; Choi JG; Zeng M
    J Control Release; 2015 Jun; 207():70-6. PubMed ID: 25858415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses.
    Song MS; Pascua PN; Lee JH; Baek YH; Park KJ; Kwon HI; Park SJ; Kim CJ; Kim H; Webby RJ; Webster RG; Choi YK
    J Virol; 2011 Jul; 85(13):6275-86. PubMed ID: 21507962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
    Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.